May 29, 2022 03:35 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
India slams Islamic nations' organisation for 'unacceptable' comments on Yasin Malik case | Buttler batters RCB for RR's smooth sailing into IPL final | Fire reported at Ather Energy's dealership in Chennai, no one injured | Body of Kashmir man to be exhumed 6 months after controversial encounter, orders court | Accused of molesting granddaughter, ex-Uttarakhand minister kills self
Johnson & Johnson net earnings up 41.9 pc in 2021 to $20.9 bln Johnson & Johnson

Johnson & Johnson net earnings up 41.9 pc in 2021 to $20.9 bln

India Blooms News Service | @indiablooms | 26 Jan 2022, 11:08 pm

Washington/UNI/Sputnik: The net earnings of Johnson & Johnson, the world's largest manufacturer of pharmaceutical products, increased by 41.9 percent year-on-year in 2021 to $20.878 billion, the American company said on Tuesday.

 "Our 2021 performance reflects continued strength across all segments of our business. Guided by Our Credo, I am honored to assume the role of CEO, leading our global teams in continuing our work to deliver life-changing solutions to consumers, patients, and health care providers," CEO Joaquin Duato said.

In November, the American multinational corporation announced its decision to split into two companies to separate their consumer and pharmaceutical products.

One company is now focused on household products, including Neutrogena, AVEENO, Tylenol, Listerine, JOHNSON's, and BAND-AID, while the other is a medical division developing prescription drugs, including one that became a Covid-19 vaccine.

The New Jersey-based corporation, which was founded in the 1880s, has scheduled its separation in 18 to 24 months.

Related Images
FOHMA addresses press conference 01 Jan 1970, 05:30 am
Related Videos
PM Modi on Union Budget 2022-2023 01 Feb 2022, 06:28 pm
IBNS Live Business Chat 30 Dec 2021, 05:53 pm